Category: Company News
-

Elbit Systems Wins More Than $370 Million in CBP Contracts Through 2029
Elbit Systems (NASDAQ:ESLT) announced that its U.S. subsidiary, Elbit Systems of America, has been awarded multiple contracts from U.S. Customs and Border Protection (CBP) worth more than $370 million, with work scheduled to continue through May 2029. Key Investor Takeaways Why ESLT Stock Is in Focus Elbit Systems announced that Elbit Systems of America received…
-

Baosheng Signs AI Tourism Platform MOU to Expand AI Commercialization Strategy
Baosheng Media Group (NASDAQ:BAOS) has signed a non-binding memorandum of understanding (MOU) with Beijing Zhongcheng Kexin Technology Development Co., Ltd. to explore the development of an AI-powered marketing and service platform for tourist attractions, marking another step in the company’s AI commercialization roadmap. Key Investor Takeaways Why BAOS Stock Is in Focus Baosheng announced a…
-

Digital Brands Group Expands AVO Collegiate Licensing Program and Appoints Former Vuori Executive to Board
Digital Brands Group (NASDAQ:DBGI) has appointed former Vuori Chief Digital Officer David Sosnowski to its Board of Directors while expanding its AVO collegiate licensing program from one to 22 university partnerships, positioning both initiatives ahead of the upcoming U.S. college football season. Key Investor Takeaways Why DBGI Stock Is in Focus Digital Brands Group announced…
-

Glucotrack Completes Lōkahi Therapeutics Business Combination, Creating AI-Driven Healthcare Platform
Glucotrack has completed its business combination with Lōkahi Therapeutics, transforming the company into a Lōkahi-controlled public platform focused on acquiring and advancing healthcare assets while retaining its continuous blood glucose monitoring business as a standalone subsidiary. Key Investor Takeaways Why GCTK Stock Is in Focus Glucotrack (NASDAQ:GCTK) announced the completion of its previously announced business…
-

Dateline Resources Reports Rare Earth Mineralisation Across Music Valley Targets, With Rock Samples Up to 7.1% TREO
Dateline Resources reported widespread rare earth mineralisation from initial field sampling at its Music Valley project in California, with all collected rock samples returning anomalous rare earth results and the highest assay reaching 7.13% total rare earth oxides (TREO). Key Investor Takeaways Why DTREF Stock Is in Focus Dateline Resources (USOTC:DTREF) announced encouraging initial exploration…
-

Phio Pharmaceuticals Expands Global Patent Portfolio With New International Patent Milestones
Phio Pharmaceuticals has strengthened the intellectual property protection surrounding its INTASYL® gene silencing platform after receiving multiple favorable patent decisions across the United States, Canada, and Japan. Key Investor Takeaways Why PHIO Stock Is in Focus Phio Pharmaceuticals (NASDAQ:PHIO) announced multiple patent milestones that further expand protection for its proprietary INTASYL® gene silencing technology. The…
-

Premier Graphene Completes Second Government Contract Milestone With Initial SEDENA Delivery
Premier Graphene and HGI Industrial Technologies have completed the first delivery under a 1,600-unit contract with Mexico’s Secretariat of National Defense (SEDENA), marking another operational milestone as the companies pursue additional government opportunities. Key Investor Takeaways Why BIEI Stock Is in Focus Premier Graphene (USOTC:BIEI) and its manufacturing partner, HGI Industrial Technologies, announced the successful…
-

Genentech’s Gazyva Receives FDA Priority Review for Primary Membranous Nephropathy
Genentech has received FDA Priority Review for Gazyva in primary membranous nephropathy, bringing the therapy closer to potentially becoming the first FDA-approved treatment for the rare autoimmune kidney disease. Key Investor Takeaways Why RHHBY Stock Is in Focus Genentech, a member of the Roche Group (USOTC:RHHBY), announced that the U.S. Food and Drug Administration has…
-

Xeriant Receives U.S. Patent for Fire-Resistant Composite Technology Supporting NEXBOARD Commercialization (USOTC:XERI)
Xeriant has secured a U.S. patent covering its proprietary fire-resistant composite technology, strengthening the intellectual property behind its NEXBOARD construction materials platform and supporting future commercialization efforts. Key Investor Takeaways Why XERI Stock Is in Focus Xeriant (USOTC:XERI) announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 12,679,047 covering the company’s…
-

BioAdaptives Announces XcellaraHeart Cardiovascular Wellness Formula Ahead of August Launch
BioAdaptives has introduced XcellaraHeart™, a new cardiovascular wellness supplement built on its Xcellara™ platform, with commercial availability scheduled to begin on August 1, 2026. Key Investor Takeaways Why BDPT Stock Is in Focus BioAdaptives (USOTC:BDPT) announced the upcoming commercial launch of XcellaraHeart™, a cardiovascular wellness formula designed to combine its existing Xcellara™ stem/progenitor cell mobilization…